BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29162097)

  • 1. Correlation between lymphatic endothelial markers and lymph node status or N-staging of colorectal cancer.
    Zhang XM; Han WX; Wang HY; He Q
    World J Surg Oncol; 2017 Nov; 15(1):204. PubMed ID: 29162097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
    Parr C; Jiang WG
    Int J Oncol; 2003 Aug; 23(2):533-9. PubMed ID: 12851706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of lymphatic markers during avian and mouse cardiogenesis.
    Karunamuni G; Yang K; Doughman YQ; Wikenheiser J; Bader D; Barnett J; Austin A; Parsons-Wingerter P; Watanabe M
    Anat Rec (Hoboken); 2010 Feb; 293(2):259-70. PubMed ID: 19938109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
    Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
    Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes.
    Kitadai Y; Kodama M; Cho S; Kuroda T; Ochiumi T; Kimura S; Tanaka S; Matsumura S; Yasui W; Chayama K
    Int J Cancer; 2005 Jun; 115(3):388-92. PubMed ID: 15688374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of intratumoural and peritumoural lymphatics expressed by podoplanin and LYVE-1 in the hybridoma-induced tumours.
    Ji RC; Eshita Y; Kato S
    Int J Exp Pathol; 2007 Aug; 88(4):257-70. PubMed ID: 17696907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
    Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
    J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First year changes of myocardial lymphatic endothelial markers in heart transplant recipients.
    Geissler HJ; Dashkevich A; Fischer UM; Fries JW; Kuhn-Régnier F; Addicks K; Mehlhorn U; Bloch W
    Eur J Cardiothorac Surg; 2006 May; 29(5):767-71. PubMed ID: 16439147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of lymphangiogenesis to progression of colorectal cancer].
    Wang TB; Huang YH; Lan P; Song XM; Wang JP
    Ai Zheng; 2005 Oct; 24(10):1276-9. PubMed ID: 16219148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of lymphangiogenic factors in human colorectal cancer with quantitative RT-PCR.
    Lu Y; Yang Q; Du Y; Feng G; Yang C
    Cancer Invest; 2007 Sep; 25(6):393-6. PubMed ID: 17882649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer.
    Ozmen F; Ozmen MM; Ozdemir E; Moran M; Seçkin S; Guc D; Karaagaoglu E; Kansu E
    World J Gastroenterol; 2011 Jul; 17(27):3220-8. PubMed ID: 21912471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
    Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
    Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Wang MH; Zha XM; Zhao Y; Wang S
    Med Oncol; 2012 Dec; 29(4):2594-600. PubMed ID: 22562155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
    Kawakami M; Furuhata T; Kimura Y; Yamaguchi K; Hata F; Sasaki K; Hirata K
    Surgery; 2003 Mar; 133(3):300-8. PubMed ID: 12660643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer.
    Shimizu K; Kubo H; Yamaguchi K; Kawashima K; Ueda Y; Matsuo K; Awane M; Shimahara Y; Takabayashi A; Yamaoka Y; Satoh S
    Cancer Sci; 2004 Apr; 95(4):328-33. PubMed ID: 15072591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer.
    Wada H; Shiozawa M; Katayama K; Okamoto N; Miyagi Y; Rino Y; Masuda M; Akaike M
    J Gastroenterol; 2015 Jul; 50(7):727-34. PubMed ID: 25725617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure.
    Dashkevich A; Bloch W; Antonyan A; Fries JU; Geissler HJ
    Lymphat Res Biol; 2009; 7(1):21-7. PubMed ID: 19254175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.
    Sotiropoulou N; Bravou V; Kounelis S; Damaskou V; Papaspirou E; Papadaki H
    Pathology; 2010 Dec; 42(7):629-36. PubMed ID: 21080871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.